LONDON/JERUSALEM – The U.K. and Israel are overhauling their COVID-19 testing policies as governments seek to reduce the burden on laboratories and struggle with tight supplies of test kits amid soaring infection rates fueled by the omicron variant.
This time last year, vaccines offered hope that the pandemic might be over by now. But omicron has brought new challenges, including overloading public health systems, even if — as many scientists say — it leads to less severe illness than the earlier delta variant.
Demand for testing kits has squeezed supply. Last week, queues formed outside pharmacies in Spain's capital, Madrid, in what has become a common scene since omicron began driving up infections. Madrid, where a conservative government has put supporting the hospitality sector at the top of its agenda, is opting for increased testing and no restrictions on socializing.
A surge in demand for tests has led to issues in the U.K. and Italy. The U.K. Health Security Agency (UKHSA) said that 100,000 more PCR booking slots per day had been made available since mid-December and that capacity had been doubled to 900,000 PCR and LFD test kits a day.
People in England who test positive for COVID-19 on rapid lateral flow device (LFD) tests will not need to confirm their results with a follow-up PCR test if they are not showing symptoms, the UKHSA said Wednesday.
KEYWORDS
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.